The global market for Fish Oil Omega-3 was estimated at US$1.2 Billion in 2024 and is projected to reach US$1.4 Billion by 2030, growing at a CAGR of 3.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Fish Oil Omega-3 market.
Global Fish Oil Omega-3 Market - Key Trends & Drivers Summarized
Why Is Fish Oil Omega-3 Gaining Renewed Importance in Global Nutrition and Preventive Health?
Fish oil omega-3, rich in essential fatty acids such as EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), has become a cornerstone of the global nutritional supplements market, valued for its scientifically supported health benefits across cardiovascular, neurological, prenatal, and inflammatory conditions. With consumers increasingly prioritizing preventive health, immunity, and longevity, fish oil omega-3 is seeing widespread adoption in both dietary supplements and functional food formulations. The shift toward proactive wellness, driven by an aging population and rising rates of non-communicable diseases such as heart disease, diabetes, and cognitive decline, is fueling long-term demand. Public health recommendations by organizations such as the American Heart Association and the World Health Organization continue to emphasize omega-3 consumption for cardiovascular support and general well-being, reinforcing its place in daily nutrition. Furthermore, as more consumers adopt clean-label, natural, and science-backed supplements, fish oil particularly in high-purity or pharmaceutical-grade forms is gaining credibility as a trusted, evidence-based ingredient. Its broad appeal spans age groups and health goals, from brain development in infants and children to joint mobility and mood support in older adults. With evolving delivery formats including capsules, soft gels, emulsions, gummies, and fortified foods, fish oil omega-3 is successfully meeting diverse consumer needs in an increasingly health-conscious global market.How Are Sustainability and Quality Standards Redefining the Fish Oil Supply Chain?
As global demand for fish oil omega-3 rises, sustainability and traceability are becoming central concerns across the supply chain, prompting companies to innovate and adapt. Overfishing and marine ecosystem degradation have intensified scrutiny on fish oil sourcing practices, leading to an industry-wide shift toward certified sustainable fisheries and alternative sourcing models. Certifications from bodies like the Marine Stewardship Council (MSC) and the International Fish Oil Standards Program (IFOS) have become crucial quality signals for both retailers and end-users. These certifications not only guarantee environmental responsibility but also ensure product purity, oxidation levels, and contaminant-free processing. Producers are increasingly turning to by-products from fishmeal production and regulated wild-caught species such as anchovy, sardine, and mackerel reducing waste and adding value to existing marine harvests. Cold-press extraction, molecular distillation, and nitrogen-flushed processing are among the technologies being employed to preserve omega-3 potency and reduce oxidation. Additionally, advanced encapsulation techniques are enhancing bioavailability and minimizing the fishy aftertaste often associated with traditional fish oil supplements. As transparency becomes a consumer expectation, brands are investing in QR-code traceability, blockchain-based sourcing data, and third-party lab reports to build trust and differentiation. These developments are not only raising quality and environmental benchmarks across the industry but are also helping fish oil omega-3 align with broader ESG (Environmental, Social, Governance) goals in the global health and nutrition sector.What Role Do Functional Foods, Pharma Applications, and Lifestyle Trends Play in Market Growth?
Fish oil omega-3 is increasingly moving beyond the supplements aisle, finding its way into a diverse array of functional foods, medical nutrition, and even pharmaceutical-grade applications. As consumers seek more convenient ways to meet their daily nutrient requirements, omega-3-enriched beverages, dairy alternatives, cereals, baby food, and snack bars are gaining popularity across North America, Europe, and parts of Asia-Pacific. This shift is driven by lifestyle trends favoring on-the-go nutrition, minimal supplementation regimens, and wellness-infused food choices. In the pharmaceutical sector, prescription-strength fish oil products such as icosapent ethyl are approved for managing high triglyceride levels and reducing cardiovascular event risk in high-risk patients, expanding omega-3's clinical relevance. Pediatric and prenatal applications also continue to grow, supported by strong evidence linking DHA to fetal brain and visual development. In sports nutrition, fish oil is being explored for its role in reducing exercise-induced inflammation and enhancing recovery. Wellness-focused consumers are also turning to omega-3 for mood support, cognitive clarity, skin health, and hormonal balance, creating demand across life stages. Brands are responding with format innovations like omega-3 gummies for children, flavored oils for culinary use, and microencapsulated powders for smoothies or meal replacements. This functional and lifestyle-driven diversification is allowing fish oil omega-3 to penetrate new market segments, elevating it from a standalone supplement to an integrated component of everyday health and nutrition solutions.What's Fueling the Global Surge in Demand for Fish Oil Omega-3 Products?
The growth in the global fish oil omega-3 market is driven by several interconnected factors related to health trends, product innovation, supply chain maturity, and demographic shifts. A key driver is the increasing global focus on preventive health, especially among aging populations and health-conscious millennials, both of whom seek natural and clinically validated solutions for long-term well-being. The proven cardiovascular, cognitive, prenatal, and anti-inflammatory benefits of omega-3s have made fish oil a cornerstone of personalized nutrition plans recommended by health professionals. Another major growth catalyst is the expanding body of clinical research and regulatory approvals that continue to affirm the therapeutic value of omega-3s across multiple health categories. Technological improvements in extraction, purification, and encapsulation have enhanced product quality, palatability, and bioavailability, expanding appeal across consumer groups. The rising popularity of functional foods and beverages fueled by convenience, lifestyle alignment, and holistic wellness is integrating omega-3s into everyday consumption patterns. Moreover, the growing adoption of e-commerce and direct-to-consumer channels has widened global access to high-quality fish oil products, especially in emerging markets. Regulatory harmonization in regions such as the EU, US, and Asia-Pacific is also streamlining product approval and market entry processes. Finally, sustainability efforts in sourcing, coupled with transparency-driven marketing and third-party testing, are building consumer trust and driving brand differentiation. These multidimensional drivers spanning health priorities, innovation, regulation, and ethical sourcing are propelling the fish oil omega-3 market toward robust, long-term global expansion.Key Insights:
- Market Growth: Understand the significant growth trajectory of the Anchovy segment, which is expected to reach US$350.0 Million by 2030 with a CAGR of a 2.6%. The Herring segment is also set to grow at 2.6% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $321.2 Million in 2024, and China, forecasted to grow at an impressive 6.1% CAGR to reach $281.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Fish Oil Omega-3 Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Fish Oil Omega-3 Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Fish Oil Omega-3 Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as ADM, Aker BioMarine, Barlean’s Organic Oils, BASF SE, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 42 companies featured in this Fish Oil Omega-3 market report include:
- ADM
- Aker BioMarine
- Barlean’s Organic Oils
- BASF SE
- Cargill, Inc.
- Carlson Laboratories
- Colpex International S.A.C
- Corbion NV
- Croda International Plc
- DSM-Firmenich
- Epax
- GC Rieber VivoMega AS
- Golden Omega
- KD Pharma Group SA
- Kerry Group Plc
- Luhua Biomarine Co., Ltd.
- Lysi hf
- Nordic Naturals
- Omega Protein Corporation
- Pelagia AS
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ADM
- Aker BioMarine
- Barlean’s Organic Oils
- BASF SE
- Cargill, Inc.
- Carlson Laboratories
- Colpex International S.A.C
- Corbion NV
- Croda International Plc
- DSM-Firmenich
- Epax
- GC Rieber VivoMega AS
- Golden Omega
- KD Pharma Group SA
- Kerry Group Plc
- Luhua Biomarine Co., Ltd.
- Lysi hf
- Nordic Naturals
- Omega Protein Corporation
- Pelagia AS